Search This Blog

Saturday, June 2, 2018

Nabriva Therapeutics initiated at buy by Northland

Nabriva Therapeutics initiated with an Outperform at Northland. Northland initiated Nabriva Therapeutics with an Outperform and $17.50 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)